Search - tctmd.com

Displaying 81 - 100 of 214

Sort: Relevancy | Date

COVID-19: TCTMD’s Dispatch for October Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 3

October 18, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

Compensation in 2020 Survived COVID-19, CV Professionals Say

News Daily News

Compensation in 2020 Survived COVID-19, CV Professionals Say

September 10, 2021

Female Trainees Still Dissuaded by Electrophysiology ‘Old Boys’ Club,’ Says ACC Survey

News Daily News

Female Trainees Still Dissuaded by Electrophysiology ‘Old Boys’ Club,’ Says ACC Survey

August 23, 2021

PAD Continues to Elude Clinicians, Despite Gains: AHA

News Daily News

PAD Continues to Elude Clinicians, Despite Gains: AHA

August 05, 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

News Conference News TVT 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

July 26, 2021

Tobacco Use Still Rampant Among CVD Patients Who Know Better

News Daily News

Tobacco Use Still Rampant Among CVD Patients Who Know Better

Yael L. Maxwell

June 09, 2021

COVID-19: TCTMD’s Daily Dispatch for June Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 2

June 07, 2021

COVID-19: TCTMD’s Daily Dispatch for June Week 1

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 1

June 01, 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

COVID-19: TCTMD’s Daily Dispatch for May Week 3

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May Week 3

May 17, 2021

COVID-19: TCTMD’s Daily Dispatch for May Week 1

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May Week 1

May 02, 2021

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

TCTMD’s Top 10 Most Popular Stories for March 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2021

April 02, 2021

AHA Seeks to Drive Down Amputations 20% by 2030

News Daily News

AHA Seeks to Drive Down Amputations 20% by 2030

April 01, 2021

Did Regional Differences Muddy Results in COMMANDER-HF?

News Daily News

Did Regional Differences Muddy Results in COMMANDER-HF?

February 04, 2021

Excluded from Pivotal Trials, Low-risk Complex Patients Warrant Caution

News Daily News

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

January 22, 2021

COVID-19: TCTMD’s Daily Dispatch for December

News Daily News

COVID-19: TCTMD’s Daily Dispatch for December

December 01, 2020

Simple Tech Empowers HF Patients, Boosting Health: EPIC-HF and MyROAD

News Conference News AHA 2020

Simple Tech Empowers HF Patients, Boosting Health: EPIC-HF and MyROAD

November 18, 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.